Roxanne Boyd
Family Medicine · Alexandria, LANPI 1801281191
Payments from drug & device makers
Across 191 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Astellas Pharma US Inc$339
- Lilly USA, LLC$292
- Novo Nordisk$288
- Axsome Therapeutics, Inc.$268
- GSK$235
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,96397%
- Education$1423%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $727 |
| Astellas Pharma US Inc | 10 | $339 |
| Lilly USA, LLC | 10 | $292 |
| Novo Nordisk | 10 | $288 |
| Axsome Therapeutics, Inc. | 13 | $268 |
| GSK | 9 | $235 |
| Pfizer | 7 | $191 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $168 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Abbott | 7 | $125 |
| Vanda Pharmaceuticals Inc. | 6 | $111 |
| Mylan Specialty L.p. | 5 | $110 |
| Vifor Pharma, Inc. | 1 | $107 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Verona Pharma, Inc. | 4 | $101 |
| Boston Scientific | 1 | $100 |
| AstraZeneca | 6 | $95 |
| Evofem Biosciences, Inc. | 5 | $87 |
| Exact Sciences | 5 | $82 |
| Viatris Specialty LLC | 4 | $74 |
| Amgen | 3 | $58 |
| Myriad Women's Health, Inc. | 1 | $48 |
| Mannkind Corporation | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Gilead | 2 | $32 |
| Cequr Corporation | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Insulet Corporation | 1 | $23 |
| Alkermes, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
| Merck | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
- AREXVY$123
- Veltassa$107
- GENERAL - THERAPIES$100
- MOUNJARO$100
How this compares
$4,106 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 112 | $110,913 |
| OzempicSemaglutide | 98 | $99,853 |
| VraylarCariprazine Hcl | 41 | $57,893 |
| MounjaroTirzepatide | 39 | $40,491 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 52 | $37,681 |
| EliquisApixaban | 40 | $29,938 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 82 | $23,309 |
| JanuviaSitagliptin Phosphate | 23 | $22,137 |
| VeozahFezolinetant | 29 | $16,323 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 72 | $13,870 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,545 |
| QuliptaAtogepant | 11 | $12,139 |
| TrulicityDulaglutide | 11 | $10,561 |
| FarxigaDapagliflozin Propanediol | 15 | $9,915 |
| EntrestoSacubitril/Valsartan | 14 | $9,438 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $15 | $110,913112 claims |
| Novo NordiskOzempic | $288 | $99,85398 claims |
| AbbVieVraylar, Qulipta, Linzess | $727 | $78,10363 claims |
| Lilly USA, LLCMounjaro, Trulicity | $292 | $51,05350 claims |
| GSKTrelegy Ellipta | $235 | $37,68152 claims |
| PfizerEliquis | $191 | $29,93840 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $95 | $29,55356 claims |
| MerckJanuvia | $14 | $22,13723 claims |
| Astellas Pharma US IncVeozah | $339 | $16,32329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Alexandria
- Michael ScrepetisAlexandria$27K
- Gregory BevelsAlexandria$24K
- Kenneth BrownAlexandria$17K
- Gregory BrianAlexandria$15K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.